A competitive antagonist of the nucleotide receptor P2X7 (pIC50 = 6.9); inhibits both calcium flux and IL-1β release mediated by P2X7 while not affecting the activity of other P2X receptors; used to evaluate the role of P2X7 in nociception, oxidative stress, and apoptosis in cells and animals.